SCHEMBL23552255

SCHEMBL23552255

CCOC(=O)OC[C@H]1O[C@@H](OC2=C(C)OC(=C(C)C)C2=O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC5A1 P13866 5/20 0.48
▸ SLC5A2 P31639 5/20 0.48
▸ SLC28A3 Q9HAS3 2/20 0.35
▸ PTPN1 P18031 1/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ TLR4 O00206 1/20 0.34
▸ PRKD3 O94806 1/20 0.33
▸ PRKCG P05129 1/20 0.33
▸ PRKCB P05771 1/20 0.33
▸ PRKCA P17252 1/20 0.33
▸ PRKCH P24723 1/20 0.33
▸ PRKCI P41743 1/20 0.33
▸ PRKCE Q02156 1/20 0.33
▸ PRKCQ Q04759 1/20 0.33
▸ PRKCZ Q05513 1/20 0.33
▸ PRKCD Q05655 1/20 0.33
▸ PRKD1 Q15139 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25632110 0.83 SLC28A3 (0.47) SLC5A2SLC28A3PTPN1HIF1AESR1
SCHEMBL23552257 0.83 SLC28A3 (0.47) SLC5A2SLC28A3PTPN1HIF1AESR1
SCHEMBL10031325 0.75 SLC5A1 (0.63) SLC5A1SLC5A2CYP2C9CYP2C19TDP1
SCHEMBL10031321 0.75 SLC5A1 (0.63) SLC5A1SLC5A2CYP2C9CYP2C19TDP1
SCHEMBL10031320 0.73 SLC5A1 (0.52) SLC5A1SLC5A2CYP2C19TLR4PRKD3
SCHEMBL23552378 0.72 CYP2D6 (0.54) PTPN1THRBHSD17B10
SCHEMBL23552395 0.72 CYP2D6 (0.54) PTPN1THRBHSD17B10
SCHEMBL23552311 0.69 P4HB (0.40) THRBHSD17B10
SCHEMBL23552404 0.69 P4HB (0.44) CYP2C9THRBHSD17B10
SCHEMBL17866100 0.68 ALDH1A1 (0.45) SLC5A1SLC5A2CYP2C9CYP2C19TLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11673909-B2 Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof FUDAN UNIVERSITY (CN) 2023-06-13 — — US disclosed
US-11673909-B2 Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof FUDAN UNIVERSITY (CN) 2023-06-13 — — US disclosed
WO-2021121362-A1 FURANEOL GLYCOSIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 复旦大学 2021-06-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11673909-B2 Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof FAR1, CYP4A11, SFRP1 SLC5A1 15/4885SLC5A2 116/4885SLC28A3 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback